 07 PM / in 12 minutes BRIEF-Gemphire Completes Patient Enrollment In Indigo-1 Trial Reuters Staff 
Jan 17 (Reuters) - Gemphire Therapeutics Inc: 
* GEMPHIRE COMPLETES PATIENT ENROLLMENT IN INDIGO-1 TRIAL IN SEVERE HYPERTRIGLYCERIDEMIA (SHTG) PATIENTS 
* GEMPHIRE THERAPEUTICS INC - ON TRACK TO REPORT TOP-LINE DATA FROM PHASE 2B TRIAL IN Q2 OF 2018 Source text for Eikon: Further company coverage: